Cardiovascular Medicine

1 pages, 211 KB

Open AccessInteresting Images

by Jean-Jacques Goy, Laurent Poncioni, Patrick Monnier, François Perret and John Wellinger

Cardiovasc. Med. 2010, 13(10), 318; https://doi.org/10.4414/cvm.2010.01530 - 13 Oct 2010

Viewed by 4

A 46-year-old woman patient was admitted for transient ischaemic attack. She was not taking medication and had no history of cardiac or vascular problems [...] Full article

1 pages, 156 KB

Open AccessInteresting Images

Lipämisches Serum…

by Christoph Henzen

Cardiovasc. Med. 2010, 13(10), 317; https://doi.org/10.4414/cvm.2010.01531 - 13 Oct 2010

Viewed by 7

Abstract

Ein 47-jähriger Sanitärinstallateur tritt notfallmässig mit Oberbauchschmerzen, Nausea und mehrmaliger Emesis ein [...] Full article

4 pages, 142 KB

Open AccessCase Report

Churg-Strauss Syndrome

by Sina Lautwein, Frank Enseleit, Urs Schwarz and Thomas F. Lüscher

Cardiovasc. Med. 2010, 13(10), 313; https://doi.org/10.4414/cvm.2010.01533 - 13 Oct 2010

Viewed by 10

Abstract

A 62-year-old patient was admitted to our hospital because of severe fatigue, headache, arthralgias, myalgias and an unsteady gait. She presented with a reduced general condition and splinter haemorrhages of the fingers. Due to a known history of asthma, signs of eosinophilia, sinusitis, endomyocardial thrombotic apposition in both chambers and neurological deterioration, the diagnosis of multisystem vasculitis (ChurgStrauss syndrome) was made. The symptoms resolved after steroid therapy. Churg-Strauss syndrome is a rare necrotising systemic inflammatory vasculitis of the small and medium-size vessels. Typically, the disease has three distinct stages, which can possibly involve several organic systems (e.g., pulmonary, cardial, renal and nervous system). The treatment for ChurgStrauss syndrome includes steroids and/or other immunosuppressive drugs. After introduction of steroid therapy, the prognosis of the disease improves significantly, but heart failure remains as a major determinant of mortality. Full article

4 pages, 256 KB

Open AccessCase Report

Die Fontan-Konversion—Oder das Schicksal, Die Erste zu Sein

by Kerstin Wustmann, Alexander Kadner, Jean-Pierre Pfammatter, Etienne Delacrétaz, Thierry Carrel and Markus Schwerzmann

Cardiovasc. Med. 2010, 13(10), 309; https://doi.org/10.4414/cvm.2010.01532 - 13 Oct 2010

Viewed by 10

Abstract

We report the case of the first patient with tricuspid atresia in whom an “old-fashioned” Fontan operation with an atriopulmonary anastomosis was performed in our hospital 18 years ago. Complications of the former “classical” Fontan circulation can include progressive right atrial dilatation leading to tachyarrhythmias, flow energy loss, obstruction of pulmonary veins, right atrial thrombi and the formation of pulmonary arteriovenous fistulas. In order to palliate our patient from recurrent atrial tachyarrhythmias and increasing haemodynamic disturbances, the previous “old-fashioned” Fontan circulation was surgically revised and converted according to a “modern” type of extracardiac Fontan circulation with additional anti-arrhythmic procedures. The post-operative course was uneventful. After recovery from surgery, the patient’s quality of life improved. She is free from atrial tachycardias and shows an increased exercise capacity. We will briefly discuss the complications of the classical Fontan circulation and the possible risks of the Fontan conversion. After having been the first Fontan patient in our center, our patient was again the first to require a major revision of its circulation. Full article

7 pages, 850 KB

Open AccessEditorial

Suivi à Distance de Stimulateurs Cardiaques et Défibrillateurs Implantables: État des Lieux

by David Senouf and Haran Burri

Cardiovasc. Med. 2010, 13(10), 302; https://doi.org/10.4414/cvm.2010.01535 - 13 Oct 2010

Viewed by 9

Abstract

Introduction of wireless technology to certain pacemakers and implantable cardioverter defibrillators allow them to automatically communicate with home transmitters, which then relay data to the physician. In the United States, theses systems are widely used for remote monitoring and follow-up of patients with implantable devices since several years, and have been more recently introduced in Switzerland. In this article, we describe the currently existing systems, review the evidence regarding remote monitoring of pacemakers and defibrillators, and discuss some pending issues. Full article

5 pages, 271 KB

Open AccessReview

Neue Empfehlungen zur Antibiotischen Endokarditisprophylaxe: Pädiatrische Applikation

by Joëlle Günthard and Walter Knirsch

Cardiovasc. Med. 2010, 13(10), 297; https://doi.org/10.4414/cvm.2010.01534 - 13 Oct 2010

Cited by 1 | Viewed by 7

Abstract

Infective endocarditis in childhood is still associated with considerable morbidity and mortality. Based on the new Swiss guidelines for prophylaxis, paediatric cardiologists have worked out a consensus which is presented in this place. Special attention is paid to the difference between paediatrics and adult medicine concerning prophylaxis. Furthermore the reasons why extreme caution is needed in childhood are shown. In addition to the propositions in the new guidelines the Swiss Society of Paediatric Cardiology recommend antibiotic endocarditis prophylaxis for unoperated acyanotic heart defects with a risk of endothelial lesions (aortic valve lesions and VSD). In childhood, endocarditis prophylaxis covers meticulous dental hygiene and selective antibiotic therapy if there is a risk of bacteraemia. Overtreatment, that is giving broad spectrum antibiotics for viral infections or fever of unknown origin has to be avoided. To evaluate the new “guidelines” and potential further modifications a prospective data collection of paediatric endocarditis cases in Switzerland is mandatory. Full article

Journal Menu

Journal Browser

Cardiovasc. Med., Volume 13, Issue 10 (10 2010) – 6 articles

Further Information

Guidelines

MDPI Initiatives

Follow MDPI